Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bionoid Pharma Inc (OP:BINP)

0.0230 UNCHANGED
Streaming Delayed Price Updated: 3:43 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionoid Pharma Inc

InvestorNewsBreaks – AI Maverick Intel, Inc. (OTCID: BINP) Engages IBN to Lead Corporate Communications Strategy
Via Investor Brand Network
Topics Artificial Intelligence
AI Maverick Intel Inc. (BINP) Is ‘One to Watch’
Via Investor Brand Network
Topics Artificial Intelligence
IBN Initiates Coverage of AI Maverick Intel Inc.
Via ACCESS Newswire
AINewsBreaks – AI Maverick Intel Inc. (OTC PINK: BINP) Launches Full-Scale AI Prospecting Engine for Automated Sales Engagement
Via Investor Brand Network
Topics Artificial Intelligence
Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval
Via ACCESS Newswire
Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap
Via ACCESSWIRE
Bionoid Pharma, Inc. Acquires AI Maverick Intel
Via ACCESSWIRE
InvestorNewsBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Launches Full-Scale AI Prospecting Engine for Automated Sales Engagement
Via Investor Brand Network
Topics Artificial Intelligence
AI Maverick Launches Enhanced Prospecting Platform to Deliver Human Like Outreach - No SDR Team Required
Via ACCESS Newswire
AI Maverick Launches Enhanced Prospecting Platform to Deliver Human-Like Outreach—No SDR Team Required
From AI Maverick Intel, Inc.
Via GlobeNewswire
Bionoid Pharma Inc. Provides Update on Binding Letter of Intent to Acquire Global Alerts Corp.
Via ACCESSWIRE
Bionoid Pharma Signs Exclusive License Agreement with Global Alerts Corp.
Via ACCESSWIRE
Bionoid Pharma Extends Letter of Intent to Acquire Global Alerts Corp.
Via ACCESSWIRE
TechMediaBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Rebrands as AI Maverick Intel to Focus on AI-Driven Engagement
Via Investor Brand Network
Topics Artificial Intelligence
Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
Via ACCESS Newswire
Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit
Via ACCESS Newswire
Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements
Via ACCESS Newswire
Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity
Via ACCESS Newswire
Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm
Via ACCESS Newswire
Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025
Via ACCESSWIRE
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.
Via ACCESSWIRE
Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.
Via ACCESSWIRE
AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast
Via ACCESSWIRE
The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time
Via ACCESSWIRE
Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion
Via ACCESSWIRE
Bionoid Pharma, Inc. Signs Binding Letter of Intent to Acquire Main E-Commerce Platform of Your Supplement Supply Store Ltd.
Via ACCESSWIRE
Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit
Via ACCESSWIRE
Bionoid Pharma Announces Agreement to Acquire AiMaverickIntel.com
Via ACCESSWIRE
Bionoid Pharma Announces Letter of Intent to Acquire Global Alerts Corp.
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.